Renal dysfunction manifesting as low glomerular ... mortality and morbidity in patients with hypertension or cardiac disease. One such study was a secondary analysis of the Hypertension Detection ...

A groundbreaking study revealed that platelet distribution width (PDW) could be used as a useful non-invasive biomarker for ...

Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves a gradual loss of kidney function.

It is a common belief that low-dose dopamine may be helpful in the prevention and treatment of acute renal failure and is being widely used in these situations. Does dopamine have a beneficial ...

even in advanced chronic kidney disease; cysts derived from proximal tubules, but not those derived from distal tubules, contained increased concentrations of bioactive erythropoietin.

In the RESILIENT trial, mobile health cardiac rehabilitation did not significantly improve outcomes in older adults who went home after being hospitalized for ischemic heart disease. (JAMA Network ...

Breakthrough in diabetes treatment! The US FDA approves Ozempic for reducing kidney disease risk in diabetic patients. Learn ...

This approval marks Ozempic as the first GLP-1 treatment option for type 2 diabetes and chronic kidney disease, after showing a 24% reduction in death and major cardiac events. The U.S. FDA has ...